Derivation of the sequence of the signal peptide in human C4b-binding protein and interspecies cross-hybridisation of the C4bp cDNA sequence  by Lintin, S.J. et al.
Volume 232, number 2, 328-332 FEB 05819 May 1988 
Derivation of the sequence of the signal peptide in human 
C4b-binding protein and interspecies cross-hybridisation of the 
C4bp cDNA sequence 
S.J. Lintin*, A.R. Lewin+ and K.B.M. Reid 
MRC immunochemistry Unit, Department of Biochemrstry, University of Oxford, South Parks Road, Oxford OX1 3QU 
and + Imperial Cancer Research Fund, PO Box 123, Lincoln’s Inn Field, London WCZA 3PX, England 
Received 19 February 1988 
A 5’ cDNA clone coding for human C4b-binding protein (C4bp) was isolated, characterised and sequenced to complete 
the cDNA sequence coding for residues 1-32 thus confirming the protein sequence data of Chung et al. [(1985) Biochem. 
J. 230, 133%1411. The sequence xtended to allow derivation of the putative leader peptide sequence which was 32 residues 
in length and showed a high of hydrophobicity typical of other documented leader sequences. Cross hybridisation was 
detected between the human C4bp cDNA probes and genomic DNA isolated from various species on Southern blots 
suggesting that genomic sequence. homologous to that coding for C4bp has been conserved uring evolution. 
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1. INTRODUCTION 
C4b-binding protein (C4bp) is one of a group of 
proteins which collectively regulate the two 
pathways of complement activation and are now 
known to be genetically linked (reviews [ 1,2]). It is 
a serum glycoprotein of 550 kDa and is thought to 
be composed of 7 identical disulphide-bond linked 
subunits [3]. Each subunit is composed of eight in- 
ternally homologous repeat units, defined as short 
consensus repeats (SCR) [4], which are approx- 
imately 60 amino acids long, and constitute the 
amino-terminal 491 residues [5]. The carboxy- 
terminal 58 residues show no similarity in sequence 
to the remainder of the chain and are thought to be 
involved in the disulphide-bonded ‘core’ of the 
molecule [5]. Other complement and non- 
complement proteins have been found to contain 
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varying numbers of SCRs suggesting that C4bp is 
a member of the recently defined SCR superfamily 
h71. 
The complete amino acid sequence of C4bp was 
elucidated by a combination of cDNA and peptide 
sequencing [5]. Overlapping cDNA clones, isolated 
by Chung et al. [5] included the cDNA coding for 
amino acid residues 32-549 and N-terminal pro- 
tein sequence data included amino acid residues 
l-40. This paper reports the subsequent isolation 
of a cDNA clone which confirmed and extended 
the N-terminal protein data allowing derivation of 
the signal peptide sequence. 
C4bp has also been isolated from mouse [8,9] 
and guinea pig [lo] and in both cases is thought to 
be composed of multiple subunits, similar in size to 
those found in human C4bp. The complete amino 
acid sequence of mouse C4bp was derived from 
cDNA data and shown to have an overall identity 
of 5 1%) at the amino acid level, with the human 
sequence [l 11. As in the human sequence the 
amino terminus of the mouse sequence contains 
contiguous SCRs. There are, however, only 6 
SCRs within each mouse C4bp monomer com- 
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pared with 8 in the human sequence. The cDNA se- 
quence coding for human C4bp has been used as a 
probe to demonstrate the presence of a region of 
conserved genomic sequence in a variety of dif- 
ferent species. 
1.7 kb were selected for further analysis. Com- 
prehensive restriction maps together with limited 
nucleotide sequencing demonstrated that both 
clones overlapped extensively with known cDNA 
data and that pBP51 extended into the 5 ’ un- 
translated region (fig.1). 
2. MATERIALS AND METHODS 
2.1. Enzymes 
Restriction endonucleases were purchased from New England 
Biolabs, Boehringer Mannheim and Amersham International. 
The nick translation ‘kit’ and all radiolabelled nucleotides were 
also from Amersham International. 
2.2. Isolation and characterisation of 5 ’ cDNA clones 
Approximately 30000 colonies of a cDNA library constructed 
from human liver poly(A+) RNA [12] were screened with the 
C4bp cDNA probe, A400 [5] using the nitrocellulose replica 
filter preparation techniques [12]. Filters were hybridised for 
16 h at 42°C in a buffer containing 50% formamide [14]. The 
probe was radiolabelled using nick translation 1151 to a specific 
activity of -10’ cpm/pg and used at a final concentration of 6 
x 10’ cpm per ml hybridisation buffer. 
Plasmid DNA was prepared by the alkaline-SDS method 
[16]. Initial characterisation involved restriction site mapping 
and sequencing using the Maxam and Gilbert technique [17]. 
More extensive sequencing of the cDNA to derive the signal 
peptide and N-terminal amino acid sequence was performed us- 
ing the dideoxy chain termination method [18]. 
Thus the BgWHinfI fragment shown in fig.1 
was sequenced, the results of which are shown in 
fig.2. The use of the self-priming mechanism in the 
synthesis of the second cDNA strand, during 
library construction [ 121, introduced ‘loop backs’ 
into the double-stranded DNA and as a result the 
coding sequence in the 5 ’ region of pBP5 1 was in- 
verted and on the opposite strand (fig.1). This did 
not cause any ambiguity in this study because of 
the availability of a detailed restriction map for the 
known cDNA and peptide data for the N-terminus 
region of the protein. The extent of the 5 ’ un- 
translated region can only be derived by the use of 
Sl nuclease mapping and cannot be derived ac- 
curately from cDNA clones. 
2.3. Southern blotting 
Genomic DNA was prepared from whole blood [19], all 
samples were supplied through the Department of Biochemistry 
(Oxford) with the exception of shark blood which was a gift 
from Dr Sylvia Smith (Florida International University); for 
analysis, 8-10 ,ug was digested with 20 units of enzyme for 20 h, 
electrophoresed in 0.7% (w/v) agarose and transferred to 
nitrocellulose (Amersham) [20]. The filters were then hybridised 
using a nick translated cDNA probe as described above, the 
probe used was C4bp Sl [21]. The filters were then washed three 
times in 2 x SSC + 0.1 Vo SDS at room temperature for 20 min; 
twice in 5 x SSC at 65°C for 15 min and twice in 3 x SSC at 
65°C for 15 min. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and characterisation of 5 ’ cDNA 
clones 
The sequence derived for residue 1 (asparagine) 
through to residue 33 (cysteine) confirmed the N- 
terminal sequence determined by conventional 
protein sequencing [23] and included two cysteines 
and a proline residue involved in the consensus e- 
quence defined for the SCR [6]. When translated 
the sequence immediately 5 ’ to the first codon in 
the coding region allows derivation of the putative 
leader peptide sequence. This region of the amino 
acid sequence shows a high proportion of 
hydrophobic residues with two universal transla- 
tion initiation codons (ATG), one at position -13 
and the other at -32, the latter being preceded by 
four polar residues. The ATG at position -32 lies 
closest to the CAP site and is considered to be the 
point of initiation of translation. Thus the putative 
leader peptide is 32 residues in length for human 
C4bp. The mouse C4bp leader peptide was also 
shown to include two universal translation initia- 
tion codons at position -13 and -56 and is hence 
considered to be 56 residues in length [l 11. 
Eight positive clones were identified and the Leader peptides show no well-defined consensus 
sizes of cloned inserts assessed by agarose gel elec- sequence of amino acids but he presence of polar 
trophoresis of BamHI/NindIII restriction enzyme residues followed by a region of relatively high 
digests (the library was constructed using the hydrophobicity are well-documented features of 
PAT/&&I/~ plasmid [22] which has unique other leader peptides [24]. The hydrophobic nature 
BamHI and Wind111 sites flanking the cloning of the putative leader peptide reflects its role in an- 
site). The two clones, designated pBP51 and choring the lengthening protein in the membrane 
pBP62, containing the largest inserts of approx. during translation, thus mediating secretion of the 
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Fig. 1. Restriction map constructed for pBP51 compared with the known cDNA restriction map and primary protein structure showing 
diagrammatically the short consensus repeats. The ‘loop back’ in the new clone is marked with J and the resulting inversion of the 
coding sequence is shown with appropriate arrows. The hatched bar indicates the HinfI/L?gll fragment purified for sequencing. The 
restriction sites in the map are marked As, Asp718; Av, AvaII; Bg, Bgfl; Dd, DdeI; Hf, Hid; Pv, PvuII. 
-40 -35 
GALHRKRKYA 
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Fig.2. cDNA sequence and derived amino acid sequence for the HinfI/Bgll fragment from clone pBP51. The underlined sequence 
corresponds to the N-terminus peptide sequence [23]. The two universal translation initiation codons (ATG) are boxed and the 
hydrophobic residues in the leader peptide are marked *. Sequence 5’ to the codon for residue - 32 (ATG) corresponds to the 5’ 
untranslated region, the complete sequence obtained in this region is not shown as it was obtained on one strand only and appeared 
to contain cloning artefacts. 
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mature protein from the cell and into the fluid 
phase [25]. After completion of translation the 
leader peptide is cleaved from the mature protein. 
As a result of this cleavage the leader peptide se- 
quence is available only by derivation from the 
cDNA sequence. 
3.2. Inter-species cross hybridisation of the C4bp 
cDNA sequence 
Genomic DNA was prepared from the white 
blood cells of various mammalian and non- 
mammalian species as described. The restriction 
endonuclease BgflI was then used to digest the 
various DNA samples and the digests analysed us- 
ing the technique of Southern blotting as described 
in section 2.3. Similar amounts of genomic DNA 
were digested for each track and all the digests ap- 
peared complete on ethidium bromide stained gels. 
The hybridisation patterns seen are demonstrated 
in fig.3 and suggest the presence of sequences 
related to human C4bp cDNA in most species with 
the exception of shark. The hybridisation pattern 
in the track containing human genomic DNA was 
considerably more complex than is detected under 
the normally more stringent washing conditions 
[21], suggesting a possible cross-hybridisation with 
other related sequences. 
The results show that genomic sequence 
homologous to human C4bp has been conserved 
during evolution; it does not demonstrate con- 
clusively the presence of an active C4bp gene in 
these species. Many of the hybridisation patterns 
on the blots are complex, reflecting either the 
presence of more than one related sequence or the 
splitting of homologous regions of sequence by 
long regions of non-homologous intervening se- 
quence. Results from analysis of cloned genomic 
DNA in human [21] and mouse [26] suggest that in
both cases the coding sequence is split into a 
number of relatively short exons following closely 
the SCR organisation of the protein sequences, 
separated by introns of up to 6 kb which is 
reflected in complex hybridisation patterns on 
Southern blots. 
The absence of cross-hybridisation between the 
human cDNA probe and genomic DNA isolated 
from shark blood suggest that the sequence has 
diverged considerably during evolution from the 
more primitive species. This correlates with a func- 
tional study [27] in which human C4b and C3b 
Fig.3. Results of the interspecies cross-hybridisation using the 
human C4bp cDNA probe, SI(21) to hybridise genomic DNA 
isolated from various mammalian and non-mammalian species. 
were used as substrates to evaluate the presence of 
molecules serving the function of complement 
regulatory proteins in the sera of a number of dif- 
ferent species. Serum samples from the more 
primitive species including shark failed to par- 
ticipate in the regulatory functions normally at- 
tributed to C4bp [27]. 
Thus a cDNA clone was isolated which allowed 
derivation of the putative leader peptide sequence 
of C4bp and confirmation, at the cDNA level, of 
the N-terminal peptide sequence [23]. The newly 
isolated clone has subsequently been used to 
prepare a cDNA probe and the sequence has been 
used to synthesize an oligonucleotide probe, both 
of which are being used to characterise genomic 
clones covering the 5 ’ region of the human C4bp 
gene. Use of cDNA probes in Southern blot 
analysis has demonstrated the presence of se- 
quence homologous to human C4bp in many 
mammalian and non-mammalian species. 
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